| Bioactivity | EP3 antagonist 3 (compound 2) is an orally active, potent and selective EP3 antagonist, with a pKi of 8.3. EP3 antagonist 3 shows excellent pharmacokinetic properties. EP3 antagonist 3 can be used for overactive bladder (OAB) research[1]. | ||||||||||||
| Name | EP3 antagonist 3 | ||||||||||||
| CAS | 1227827-88-4 | ||||||||||||
| Formula | C21H18N2O4 | ||||||||||||
| Molar Mass | 362.38 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Jin J, et al. Novel 3-Oxazolidinedione-6-aryl-pyridinones as Potent, Selective, and Orally Active EP3 Receptor Antagonists. ACS Med Chem Lett. 2010 May 14;1(7):316-20. |
EP3 antagonist 3
CAS: 1227827-88-4 F: C21H18N2O4 W: 362.38
EP3 antagonist 3 (compound 2) is an orally active, potent and selective EP3 antagonist, with a pKi of 8.3. EP3 antagonis
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.